August 15, 2018 7:32am

It’s not a reason to invest but, a trade is different and expensive for some

Turkey is all I hear about which is maybe symptomatic since they roost in the front yard’s oak tree – does that count?  They are as noisy and do ”mess-up” the front walk; my response – stop feeding them!

 

Hey, hay is for horses, here’s another freebee!

RMi reports pre-open indications that shed light on share pricing events and today’s session values.

 

When is it wrong to be right so often?

Your portfolio should be profiting from RMi’s analysis -SUBSCRIBE!


U.S. stock index futures are pulling back

Dow futures are DOWN -0.55% (-138 points) and NASDAQ futures are DOWN -0.66% (-49 points)

 

U.S. stock index futures came under pressure ahead of Wednesday's open, while Turkey’s crisis casts a pall on “today’s” sentiment,

European markets were mixed also with concerns over the Turkish currency crisis which is affecting investors' appetite,

Asian stocks closed lower on Wednesday, with Chinese shares dropping more than 2%.

 

Data docket: routine weekly mortgage applications tumbled as homebuyers dropped out, retail sales are next with the Empire State Manufacturing survey, and productivity & costs, which are all released at 8:30 a.m. ET. At 9:15 a.m. ET, industrial production figures are scheduled to be released, followed by business inventories and the NAHB/Wells Fargo Housing Market Index at 10 a.m. ET. Treasury International Capital figures will then be released at 4 p.m. ET.

 

Henry’omics:

“Our” universe has been on a roller coaster ride since August based on 10 sessions with 4 negative and 6 positive closes as quarterly results rattle investor sentiment - which is all but over!

As low volume upside is a cautionary event or happening!

Aside from concerns over news – our focus needs to be on pricing stability and sustainability – don’t be swayed by volatility!

Thus, I say – sit on your hand or use your fingers to turn the pages!

 

Today’s indications:

  • The iShares Nasdaq Biotechnology (IBB) is indicating a -0.35% DOWNSIDE in Wednesday’s pre-market;
  • The SPDR S&P Biotech ETF (XBI) is NOT indicating in Wednesday’s pre-market;
  • The Health Care Select Sector SPDR ETF (XLV) is NOT indicating in Wednesday’s pre-open;
  • The iShares Russell 2000 (IWM) is indicating a -0.2% DOWNSIDE in Wednesday’s pre-open

 

I always want to know what happened PRIOR to what might happen today – it sets a tone of consequence:

  • From Tuesday’s night’s newsletter: “back-in the saddle again, Yodalayhe, yodayahehoo. We’re back ridin’ high and to the upside.”
  • The iShares NASDAQ Biotechnology (IBB): Tuesday’s +0.56% followed Monday’s -0.05%, Friday’s -0.55%, Thursday’s -0.15% and last Wednesday -0.70% for a five session aggregate of -2.01% - not looking for anything on Wednesday but, some pricing stability!
  • Of the 45 companies covered on Tuesday; 13 downside equities finished in a range of -$0.04 (VSTM) to -$1.79 (BOLD) while the 28 upside equities oscillated from +$0.02 (ATHX) to $2.85 (ONCE) with 4 flat closes (AST, RARE, RENE.L and BSTG);
  • Tuesday’s decliners ranged from -1.43% <AST -$0.03> to -11.11% <MDXG -$0.51> in 13 equities;
  • Tuesday’s gainers ranged from +0.26% < BLUE +$0.40> to +7.40% < FIXX +$1.16> in 28 equities;

 

Companies in my headlights – It’s your decision; I provide the idea and context:

I am sitting on the sidelines – the music on the revolving carousel starts and stops on its many riders.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.